Company / Operating Cash Flow
Bone Biologics Corp Operating Cash Flow History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$3.3M
FY2020
5-year range
-$4.6M / -$3.3M
FY2017-FY2020
Trend
+20.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$3M to -$3M over the past 2 years.
Based on SEC 10-K filings.
-$3M in FY2020.
Improved from -$3M to -$3M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating cash flow increased 20.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$3.3M | +20.8% |
| FY2019 | -$4.1M | -23.3% |
| FY2018 | -$3.3M | +26.9% |
| FY2017 | -$4.6M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026